课题基金 / 基金详情

MHC CLASS IB IMMUNITY TO AN INTRACELLULAR PATHOGEN

MHC CLASS IB IMMUNITY TO AN INTRACELLULAR PATHOGEN
MHC IB 类对细胞内病原体的免疫力
批准号:
6169777
负责人:
H. G. Archie Bouwer
金额:
$18.01万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-07-01 至 2001-06-30

项目摘要

项目成果

H. G. Archie Bouwer的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from the applicant's abstract): The protective immune response to L. monocytogenes is used to investigate cell-mediated immunity to intracellular bacteria. A necessary virulence determinant is secretion of listeriolysin O (LLO). Listeria-specific CD8+ T cells are cytotoxic in vitro, these effectors lyse L. monocytogenes infected targets. In BALB/c mice (H2d), CD8+ CTLs have been isolated which are Kd restricted, and a nanomer peptide corresponding to aa91-99 of LLO shown to be presented by the MHC Class Ia molecule. LLO-specific CD8+ T-cells have also been described which lyse L. monocytogenes infected targets in an MHC Class IB restricted manner; the antigen presenting molecule is encoded within the T-region of a less polymorphic family of MHC Class I molecules. Studies in Aim 1 will determine if LLO is an immuno-dominant antigen for MHC Class Ib restricted antilisterial CTLs. Studies in Aim 2 will determine if MHC Class Ib restricted anti-listerial cells are protective in vivo. Studies in Aim 3 will identify the LLO-derived MHC Class Ib-restricted CTL epitope. Results from these studies will provide an understanding of the role of MHC Class Ib restricted effector cell in the protective immune response to an intracellular pathogen.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Intracellular induction of Listeria monocytogenes actA expression.
细胞内诱导单核细胞增生李斯特氏菌 actA 表达。
DOI: 10.1128/iai.70.3.1087-1096.2002
发表时间: 2002
期刊: Infection and immunity
影响因子: 3.1
作者: [Shetron-Rama,LynneM, Marquis,Hélène, Bouwer,HGArchie, Freitag,NancyE]
通讯作者: Freitag,NancyE
EPITOPE DELIVERY, IMMUNODOMINANCE AND VACCINE EFFICACY
EPITOPE DELIVERY, IMMUNODOMINANCE AND VACCINE EFFICACY
EPITOPE DELIVERY, IMMUNODOMINANCE AND VACCINE EFFICACY
EPITOPE DELIVERY, IMMUNODOMINANCE AND VACCINE EFFICACY
海外基金